Immunotherapeutic potential of CD4 and CD8 single-positive T cells in thymic epithelial tumors

Indications for current immune checkpoint inhibitors are expanding and now include thymic epithelial tumors (TETs). Although clinical trials on immune checkpoint inhibitors for TETs are ongoing, a rationale has not yet been established for immunotherapy for TETs. Therefore, we herein performed pheno...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Yoko, Iwahori, Kota, Funaki, Soichiro, Matsumoto, Mitsunobu, Hirata, Michinari, Yoshida, Tetsuya, Kanzaki, Ryu, Kanou, Takashi, Ose, Naoko, Minami, Masato, Sato, Eiichi, Kumanogoh, Atsushi, Shintani, Yasushi, Okumura, Meinoshin, Wada, Hisashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055333/
https://www.ncbi.nlm.nih.gov/pubmed/32132638
http://dx.doi.org/10.1038/s41598-020-61053-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055333/
https://www.ncbi.nlm.nih.gov/pubmed/32132638
http://dx.doi.org/10.1038/s41598-020-61053-8

Ejemplares similares